Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
budesonide + ciclesonide
- Development stage
- Unknown
- Lead developer
- Azurity Pharmaceuticals
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation
01
Overview
Budesonide + ciclesonide refers to a therapeutic regimen of inhaled corticosteroids (ICS) evaluated by the National Taiwan University Hospital to determine the clinical and genetic factors influencing treatment efficacy in children with asthma. Budesonide is a non-halogenated glucocorticoid with high local anti-inflammatory potency and minimal systemic effects. Ciclesonide is a next-generation ICS prodrug that is activated by esterases in the lung to its active metabolite, desisobutyryl-ciclesonide (des-CIC). Both agents function as agonists of the glucocorticoid receptor, leading to the suppression of pro-inflammatory gene expression and the reduction of airway inflammation and hyperresponsiveness. This specific combination was studied in a Phase 4 observational trial (NCT01444105) to optimize personalized asthma management in pediatric populations.
- Brand names
- DuasmaAlvesco
- Other names
- Budesonide/CisclesonideICS in Pediatric Asthma
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on budesonide + ciclesonide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on budesonide + ciclesonide.